Abstract
We examined the feasibility of coupling the 5-HT 6 receptor to a Ca 2+ signaling read-out using a chimeric G-protein, comprising of G αq with the C-terminal five amino acids from G αs, to facilitate assays on the fluorometric imaging plate reader (FLIPR). Using a transient transfection assay in human embryonic kidney (HEK) cells, Ca 2+ signaling in response to serotonin (5-HT) was facilitated by co-transfection of the 5-HT 6 receptor with the G αq/G αs chimera, but not with the 5-HT 6 receptor alone or with a similar chimera incorporating the C-terminal five amino acids of G αi3. A series of agonist concentration–response curves were constructed using the 5-HT 6-G αq/G αs signaling assay generating the following rank order of agonist potency; 5-methoxytryptamine (EC 50, 9 nM)=5-HT (12 nM)=2-methyl 5-HT (13 nM)>tryptamine (86 nM)=5-carboxamidotryptamine (5-CT) (119 nM)≫lisuride (>1 μM). In comparison, essentially identical EC 50 values were observed for the stimulation of cAMP accumulation with the same compounds; 5-methoxytryptamine (EC 50, 6 nM)=5-HT (6 nM)=2-methyl 5-HT (15 nM)>tryptamine (91 nM)=5-CT (153 nM)>lisuride (>350 nM). Clozapine and SB 271046 both produced a concentration-dependent antagonism of the 5-HT-stimulated Ca 2+ response with IC 50 values of 45 and 11 nM, respectively. In contrast, aripiprazole, a recently launched atypical anti-psychotic with a novel mechanism of action described as a dopamine/serotonin stabilizer, was essentially devoid of 5-HT 6 receptor antagonist activity. Our results demonstrate that a FLIPR-based Ca 2+ signaling assay is a feasible approach to the functional characterization of 5-HT 6 receptor ligands. Moreover, the equivalent coupling efficiency, as indexed by agonist potency, observed using this system compared with the native coupling assay to cAMP suggests that the C-terminal five amino acids of G αs are the major determinant for the receptor/G-protein interaction of the 5-HT 6 receptor subtype.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.